Skp2: a novel potential therapeutic target for prostate cancer

Z Wang, D Gao, H Fukushima, H Inuzuka, P Liu… - … et Biophysica Acta (BBA …, 2012 - Elsevier
Prostate cancer is the most frequently diagnosed tumor in men and the second most
common cause of cancer-related death for males in the United States. It has been shown …

[HTML][HTML] Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer

AH Rezaeian, LM Phan, X Zhou, W Wei, H Inuzuka - Neoplasia, 2023 - Elsevier
SKP2, an F-box protein of the SCF type of the E3 ubiquitin ligase complex, plays an
important function in driving tumorigenesis through the destruction of numerous tumor …

Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence …

G Yang, G Ayala, AD Marzo, W Tian, A Frolov… - Clinical cancer …, 2002 - AACR
The F-box protein Skp2 (Fbl1) is a positive regulator of G1-S transition and promotes
ubiquitin-mediated proteolysis of the cyclin-dependent kinase inhibitor p27. Its …

Downregulation of critical oncogenes by the selective SK2 inhibitor ABC294640 hinders prostate cancer progression

RS Schrecengost, SN Keller, MJ Schiewer… - Molecular cancer …, 2015 - AACR
The bioactive sphingolipid sphingosine-1-phosphate (S1P) drives several hallmark
processes of cancer, making the enzymes that synthesize S1P, that is, sphingosine kinase 1 …

[HTML][HTML] Skp2 is associated with paclitaxel resistance in prostate cancer cells

Y Yang, Y Lu, L Wang, A Mizokami… - Oncology …, 2016 - spandidos-publications.com
Prostate cancer is the most commonly diagnosed tumor in men in the United States. Patients
with hormone-refractory prostate cancer are often treated with paclitaxel, but most of them …

The Skp2 pathway: a critical target for cancer therapy

Z Cai, A Moten, D Peng, CC Hsu, BS Pan… - Seminars in cancer …, 2020 - Elsevier
Strictly regulated protein degradation by ubiquitin-proteasome system (UPS) is essential for
various cellular processes whose dysregulation is linked to serious diseases including …

Skp2 regulates androgen receptor through ubiquitin‐mediated degradation independent of Akt/mTOR pathways in prostate cancer

B Li, W Lu, Q Yang, X Yu, RJ Matusik, Z Chen - The Prostate, 2014 - Wiley Online Library
BACKGROUND The intervention of advanced prostate cancer (PCa) in patients has been
commonly depending on androgen deprivation therapy. Despite of tremendous research …

High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells

Š Šimečková, Z Kahounová, R Fedr, J Remšík… - Scientific Reports, 2019 - nature.com
Skp2 is a crucial component of SCFSkp2 E3 ubiquitin ligase and is often overexpressed in
various types of cancer, including prostate cancer (PCa). The epithelial-to-mesenchymal …

Regulation of Skp2 expression and activity and its role in cancer progression

CH Chan, SW Lee, J Wang… - The Scientific World …, 2010 - Wiley Online Library
The regulation of cell cycle entry is critical for cell proliferation and tumorigenesis. One of the
key players regulating cell cycle progression is the F‐box protein Skp2. Skp2 forms a SCF …

The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy

PL Nguyen, DI Lin, J Lei, M Fiorentino, E Mueller… - … Oncology: Seminars and …, 2011 - Elsevier
BACKGROUND: In several human cancers, overexpression of Skp2 (S-phase kinase
associated protein 2), which targets p27 for degradation, portends a poorer prognosis. We …